Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × tremelimumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 23 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 6 Liver Neoplasms 6 Small Cell Lung Carcinoma 4 Diabetes Mellitus, Insulin-Dependent, 12 4 Cholangiocarcinoma 4 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Biliary Tract Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Mesothelioma 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vascular Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unresectable Hepatocellular Carcinoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

pembrolizumab 23 Cisplatin 20 Carboplatin 13 Paclitaxel 10 Radiotherapy 8 Radiotherapy, Intensity-Modulated 7 Docetaxel 7 cemiplimab 6 Nivolumab 6 Fluorouracil 6 Radiation 5 durvalumab 4 Drug Therapy 4 Taxes 3 Surveys and Questionnaires 3 Cetuximab 3 Blood Specimen Collection 3 toripalimab 2 atezolizumab 2 alpha-2'-deoxythioguanosine 2 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Petrolatum 2 Pemetrexed 2 vistusertib 1 talazoparib 1 sitravatinib 1 regorafenib 1 palbociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡